Effects of sleep disturbance, cancer-related fatigue, and psychological distress on breast cancer patients' quality of life: a prospective longitudinal observational study

Lin Tao,Jieying Lv,Ting Zhong,Xiaohong Zeng,Manxia Han,Lan Fu,Hong Chen
DOI: https://doi.org/10.1038/s41598-024-59214-0
IF: 4.6
2024-04-16
Scientific Reports
Abstract:More attention has gone to researching the cancer-related fatigue (CRF)–sleep disturbance (SD)–psychological distress (PD) symptom cluster in breast cancer patients during the chemotherapy period, but the change trend and heterogeneous development track in the whole treatment stage remain unclear, and it is also unclear whether the appearance of and changes in one symptom cause changes in other symptoms and quality of life (QoL). This study, using breast cancer patients' data collected through a validated questionnaire, examined the relationships between SD, CRF, PD, and QoL using latent growth modeling analyses. CRF developmental trajectories showed an upward trend over five surveys (slope = 0.649, P < 0.001); PD showed a significant weakening trend (slope = − 0.583, P < 0.001); SD showed an increasing trend (slope = 0.345, P < 0.001), and QoL showed a statistically significant weakening trend (slope = − 0.373, P < 0.001). The initial CRF (coefficient = − 0.233, P < 0.01), PD (coefficient = − 0.296, P < 0.01), and SD (coefficient = − 0.388, P < 0.001) levels had a statistically significant negative effect on initial QoL level. The linear development rate of PD was statistically significant and negatively affected that of QoL (coefficient = − 0.305, P < 0.05), whereas the quadratic development rate of SD negatively affected that of QoL (coefficient = − 0.391, P < 0.05). Medical staff should identify the change characteristics of different variables based on SD, CRF, PD, and QoL change trajectories, and advance the intervention time, as changes in variables affect other variables' subsequent changes.
multidisciplinary sciences
What problem does this paper attempt to address?
The main problems that this paper attempts to solve are to explore the changing trends and mutual influences of the three symptoms, namely Sleep Disturbance (SD), Cancer - Related Fatigue (CRF) and Psychological Distress (PD), during the entire treatment stage of breast cancer patients, and to study how these symptoms affect the patients' Quality of Life (QoL). Specifically, the paper aims to answer the following questions: 1. **Symptom change trends**: What are the change trends of CRF, PD and SD in breast cancer patients from diagnosis to the end of chemotherapy and subsequent follow - up? Are there heterogeneous development trajectories? 2. **Inter - relationships among symptoms**: Will the occurrence and change of one symptom lead to the change of other symptoms? Are there causal relationships among these symptoms? 3. **Impact on quality of life**: How do the changes of CRF, PD and SD affect the patients' quality of life? What are the impacts of the initial symptom levels and their change rates on QoL? ### Research background Breast cancer is one of the most common cancers among women, with more than 2 million new cases globally each year. With the progress of diagnosis and treatment technologies, the survival time of patients has been prolonged, but the quality of life has not been significantly improved. Studies have shown that cancer patients may report more than 10 symptoms during the diagnosis, treatment and rehabilitation processes. These symptoms interact with each other, seriously affecting the physical and mental health of patients and significantly reducing their quality of life. ### Research methods To answer the above questions, the researchers adopted a prospective longitudinal observational study and collected data at 5 time points (T1: one week after the initial diagnosis; T2: one week after the start of surgery; T3: one week after the end of chemotherapy; T4: six months after the end of chemotherapy; T5: 12 months after the end of chemotherapy). They measured the patients' SD, CRF, PD and QoL using validated questionnaires. The development trajectories and inter - relationships of these variables were analyzed through Latent Growth Modeling (LGM). ### Main findings 1. **Symptom change trends**: - CRF shows an upward trend (slope = 0.649, P < 0.001). - PD shows a weakening trend (slope = - 0.583, P < 0.001). - SD shows an increasing trend (slope = 0.345, P < 0.001). - QoL shows a downward trend (slope = - 0.373, P < 0.001). 2. **Impact of initial symptom levels on QoL**: - The initial levels of CRF (coefficient = - 0.233, P < 0.01), PD (coefficient = - 0.296, P < 0.01) and SD (coefficient = - 0.388, P < 0.001) have a significant negative impact on the initial QoL level. 3. **Impact of symptom change rates on QoL**: - The linear development rate of PD has a significant negative impact on the linear development rate of QoL (coefficient = - 0.305, P < 0.05). - The quadratic development rate of SD has a significant negative impact on the quadratic development rate of QoL (coefficient = - 0.391, P < 0.05). ### Conclusions and recommendations Medical staff should identify the change characteristics of different variables according to the change trajectories of SD, CRF, PD and QoL and intervene in advance, because the changes of these variables will affect the subsequent changes of other variables. Understanding the inter - relationships among these symptoms is helpful for formulating more effective comprehensive management strategies, thereby improving the quality of life of breast cancer patients. Through cross - lagged regression analysis and parallel latent growth models, this study comprehensively examined the dynamic development relationships, trajectory characteristics and interaction mechanisms among CRF, SD, PD and QoL, providing valuable references for clinical practice.